|
|
- 2019
PD‐L1 expression in ROS1‐rearranged non‐small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1Keywords: Biomarker, epidermal growth factor receptor, human ROS1 protein, non‐small cell lung carcinoma, programmed death 1 ligand 1 Abstract: The aim of the current study was to investigate the prevalence and clinicopathologic characteristics of ROS1‐rearranged non‐small cell lung cancer (NSCLC) in routine genotypic screening in conjunction with the study of PD‐L1 expression, a biomarker for first‐line treatment decisions
|
